Wuxi Fortune Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXERCALCIFEROL, with a corresponding US DMF Number 37132.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2022, and payment made on July 22, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II